Publication | Open Access
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
2.8K
Citations
17
References
2021
Year
This study in a nationwide mass vaccination setting suggests that the BNT162b2 mRNA vaccine is effective for a wide range of Covid-19-related outcomes, a finding consistent with that of the randomized trial.
| Year | Citations | |
|---|---|---|
Page 1
Page 1